Lindsey Sedlacek, in Adams, NE - Speech-Language Pathologist

Lindsey Sedlacek, is a Speech-language Pathologist based in Adams, Nebraska. Lindsey Sedlacek is licensed to practice in * (Not Available) (license number ) and her current practice location is 415 8th Street, Adams, Nebraska. She can be reached at her office (for appointments etc.) via phone at (402) 988-2525.

NPI number for Lindsey Sedlacek is 1871969733 and her current mailing address is 6701 Pine Lake Rd, Lincoln, Nebraska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1871969733.

Contact Information

	Lindsey Sedlacek,
	415 8th Street, Adams, NE 68301
	(402) 988-2525
	Not Available

Healthcare Provider's Profile

Full Name	Lindsey Sedlacek
Gender	Female
Speciality	Speech-language Pathologist
Location	415 8th Street, Adams, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1871969733
Provider Enumeration Date: 08/14/2015
Last Update Date: 08/14/2015

Medical Identifiers

Medical identifiers for Lindsey Sedlacek such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1871969733	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lindsey Sedlacek is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Lindsey Sedlacek, 6701 Pine Lake Rd, Lincoln, NE 68516-3638 Ph: (402) 239-9317	Lindsey Sedlacek, 415 8th Street, Adams, NE 68301 Ph: (402) 988-2525

News Archive

Cardiac effects associated with breast cancer treatment appear lower with dose-dense chemotherapy

A new pilot study by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) found that breast cancer patients can be treated safely with a "dose-dense" regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin), a drug that has previously been shown to cause cardiac toxicity.

New way to understand how transcranial magnetic stimulation can give relief for severe depression

A group of UK scientists have found a way of understanding how transcranial magnetic stimulation (TMS) can give relief to severely depressed patients. TMS is used as an alternative to Electro-Convulsive Therapy (ECT), but it is not known how it achieves its therapeutic effect. Understanding how it works may open the door to better, more targeted treatment for depression and other conditions.

FDA approves Boca Pharmacal's Hydrocodone Bitartrate and Acetaminophen Oral Solution ANDA

Boca Pharmacal, Inc., today announced that it has received approval from the FDA of its Abbreviated New Drug Application (ANDA) for Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5mg / 325mg per 5mL, the generic version of Hycet Oral Solution distributed by FSC Laboratories, Inc.

Obama administration ties health law to civil rights

When President Barack Obama met with African-American religious leaders just before the 50th anniversary of the March on Washington, he asked for their help in the final push to carry out the health law. Health and Human Services Secretary Kathleen Sebelius also noted the connection between access to health care and other opportunities.

Two studies shed light on joint replacement outcomes in rheumatoid arthritis patients

Two new studies by researchers at Hospital for Special Surgery have shed light on joint replacement outcomes in patients with rheumatoid arthritis. One study overturns the common belief that RA patients have worse outcomes after a total knee replacement than patients who undergo the operation for osteoarthritis. The other study demonstrates that RA patients who undergo a total hip replacement were as likely to have significant improvements in function and pain as patients with osteoarthritis, even though they did not do as well.

Lindsey Sedlacek, - Speech-Language Pathologist in Adams, NE